Nasopharyngeal secretions from 223 patients were examined for the presence of Bordetella pertussis and B. parapertussis by culturing on Regan-Lowe agar (J. Regan and F. Lowe, J. Clin. Microbiol. 6:303-309, 1977) and by direct fluorescent-antibody testing. B. pertussis was found in 38 patients; B. parapertussis was recovered from 2. Culturing was more sensitive (38 of 38 patients) than direct fluorescent-antibody testing (26 of 38 patients) for the detection of B. pertussis. Overgrowth by other organisms (7 of 223 patients) was uncommon. The patients with B. pertussis infections were generally less than 1 year old, had received no or one immunization, and had coughing spells but infrequently had whooping cough. Accurate diagnosis of B. pertussis infections should include culturing.
With the successful establishment of a nationwide immunization program in the United States against diphtheria, pertussis, and tetanus, the prevalence of these diseases fell dramatically. They have not been eliminated, however. Of the three diseases, pertussis is by far the most frequent, with ca. 1,500 to 3,000 cases reported to the Centers for Disease Control, Atlanta, Ga., annually (5) . Bordetella pertussis infection is diagnosed most frequently and is most severe in infants under 6 months old (9, 11) . B. pertussis infection is highly contagious and is rapidly spread to susceptible individuals. A decline in vaccine acceptance because of concern among parents about the safety of whole-cell pertussis vaccines may result in large outbreaks of pertussis in the United States, as was observed in the United Kingdom and Japan during the mid-1970s (11, 13) .
Until vaccine efficacy and acceptance are universal, the control of B. pertussis infection depends upon the early identification and treatment of patients with pertussis and their contacts. We present data which indicate that optimal laboratory techniques to confirm the diagnosis of B. pertussis infection must include culturing as well as direct fluorescent-antibody (DFA) testing. MATERIALS were obtained with calcium alginate nasopharyngeal swabs. Three to six slides were prepared at the bedside for DFA testing. Specimens for culturing were transported to the laboratory in 1% Casamino Acids. Upon arrival in the laboratory, each specimen was inoculated immediately onto charcoal agar (Oxoid Ltd., Columbia, Md.) supplemented with 10% sheep blood and 40 ,ug of cephalexin per ml, as described by Regan and Lowe (12) . The cultures on ReganLowe medium were incubated at 35°C in 5 to 10% CO,. The cultures were examined daily for 7 days for the presence of small, round, glistening colonies, which usually appeared after 2 to 4 days of incubation. These organisms were confirmed to be B. pertussis or B. parapertussis by the DFA techniques described below.
Each of three slides per patient were stained, usually within 24 h of arrival in the laboratory, with fluoresceinlabeled chicken anti-B. pertussis globulin and anti-B. parapertussis globulin and goat antirabbit globulin, in accordance with the manufacturer's (see below) instructions. A DFA test was considered positive for B. pertussis or B. parapertussis when short rods with a rim of bright-green fluorescence were visualized with the respective antiglobulins and no fluorescence was observed with the goat antirabbit globulin. The fluorescein-labeled antibodies against B. pertussis and B. parapertussis were purchased from Difco Laboratories, Detroit, Mich., whereas the goat antirabbit globulin, which was used as a negative control for detecting nonspecific fluorescence, was obtained from BBL Microbiology Systems, Cockeysville, Md. RESULTS B. pertussis was detected in 38 of the 223 patients studied, whereas B. parapertussis was detected in only 2 of the 223 (Table 1) . Culturing on Regan-Lowe medium was more efficient than DFA testing in detecting both B. pertussis and B. parapertussis. Twelve patients were culture positive and DFA negative for B. pertussis, and one patient was culture positive and DFA negative for B. parapertiussis. No patient was DFA positive and culture negative for either B. pertlussis or B. parapertussis. There were no instances in which DFA testing was positive for both B. pertussis and B. parapertiussis. Upon initial testing, 1 of the 38 isolates of B. pertlussis reacted with both specific conjugates. However, a repeat testing of the isolate resulted in it reacting with B. pertiussis cines in the mid-1950s. Recently, there has been concern both in the United States (7, 14) and in other developed countries (8, 15) about the safety of the vaccine. The general public has been especially wary of immunization because of reports of postvaccine encephalopathy and sudden death (15) . Because of these concerns, vaccine acceptance has dropped in both Great Britain and Japan, with resulting large epidemic outbreaks of pertussis and attendant large increases in morbidity and mortality associated with this disease. There has been increasing worry among health care officials in the United States that there may be a large increase in the number of cases of pertussis here as a result of declining pertussis vaccine acceptance (6) .
A major problem in studying the epidemiology of pertussis is making an accurate laboratory diagnosis. Several viral syndromes may be confused with both B. pertissis and B.
parapertussis infections. Prophylaxis with erythromycin can prevent the spread of B. pertussis and B. paraperttissis infections, whereas prophylactic treatment is not usually used to contain the spread of viral infections. Because of this, techniques for the laboratory diagnosis of B. pertiussis and B. parapertussis infections should be sensitive, specific, and, if possible, rapid, so that prophylaxis can be used when appropriate. Three approaches can be used to diagnosis pertussis: culturing, DFA testing, and serology. In this study, culturing on Regan-Lowe agar and DFA testing were compared, and culturing was found to be more sensitive than DFA testing for the detection of B. pertussis and B. parapertussis. This finding is in agreement with those of Regan and Lowe (12) , except that we found DFA testing to be more sensitive for the detection of the two organisms than Regan and Lowe did. In earlier studies, when culturing with Bordet-Gengou (BG) agar was compared with DFA testing, DFA testing was found to be more sensitive than culturing for the detection of B. pertussis (2, 4) . However, it was not possible to determine in these earlier studies the number of false-positive DFA results obtained. Both false-positive and false-negative DFA results can be obtained because of the variation in the interpretation of results by different investigators, as has been shown by Broome et al. (3) . In our study, there were no culture-negative and DFA-positive patients. This was probably because of the facts that >90% of the DFA results were read by the same person, the patients were usually tested early in the course of disease ( The clinical features of our patients were consistent with those seen in one other recent outbreak of pertussis (9) . The children in that study were usually less than 1 year old and had received no or one pertussis vaccine dose, and only a few had the characteristic whoop which is the hallmark of this infection. Over half the children required hospitalization (hospitalization was required mainly in very young children with this infection). This was not surprising, as most of the morbidity and mortality associated with B. pertussis occurs in this age group (8, 11 
